The Japanese chemical company has agreed to sell its pharmaceutical business to Bain Capital for more than $3 billion, in a ...

Bain Capital Private Equity has proposed to acquire the remaining shares of surgical facility operator Surgery Partners it ...

Bain Capital is making a play for full control of Surgery Partners ... Surgery Partners' strong financials$770 million in ...

On February 5, the company entered into a definitive agreement to sell an ownership stake of approximately 51% in its Milacron injection ...

Bain Capital Specialty Finance (NYSE:BCSF – Get Free Report) had its price target lifted by analysts at Wells Fargo & Company from $17.00 to $18.00 in a research note issued to investors on Wednesday, ...

CEO Hess discussed the company's divestiture of TRANZACT for $632 million, expected to enhance growth, operating margins, and free cash flow starting in 2025. The reentry into the reinsurance market ...

Sources said Bain Capital, which was among the parties weighing a first-round bid, had baulked at K1’s sky-high price ...

Apollo Global Management shares fell after KKR's rival posted a drop in quarterly revenue. Apollo Chief Executive Marc Rowan said its of Argo Infrastructure Partners, a fund manager with about $6 ...

Surgery Partners has received an acquisition offer the could take the public company private. Boston-based Bain Capital Partners has made an offer to purchase all outstanding shares of the company for ...